Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Symons

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
HSR Proceedings in Intensive Care & Cardiovascular Anesthesia|February 27, 2013
Volatile anaesthetic myocardial protection: a review of the current literatureE Lin, J A Symons
British Journal of Anaesthesia|June 24, 2006
Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysisJ A Symons, P S Myles
FEBS Letters|October 15, 1990
A soluble form of the interleukin-1 receptor produced by a human B cell lineJ A Symons, G W Duff
Cell|May 19, 1995
Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificityJ A Symons, A Alcamí, G L Smith
Rheumatology International|January 1, 1990
Interleukin 1 beta in synovial fluid is related to local disease activity in rheumatoid arthritisM Rooney, J A Symons, G W Duff
Archives of Virology. Supplementum|September 2, 1999
Immune modulation by proteins secreted from cells infected by vaccinia virusG L Smith, J A Symons, A Alcamí
Anaesthesia|December 21, 2002
Anaesthetists' attitudes towards awareness and depth-of-anaesthesia monitoringP S Myles, J A Symons, K Leslie
Journal of Virology|November 9, 2000
The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFNA Alcamí, J A Symons, G L Smith
FEBS Letters|January 29, 1990
Identification of an interleukin-1 beta binding protein in human plasmaJ A Eastgate, J A Symons, G W Duff
Cytokine|May 1, 1990
A soluble binding protein specific for interleukin 1 beta is produced by activated mononuclear cellsJ A Symons, J A Eastgate, G W Duff
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
HSR Proceedings in Intensive Care & Cardiovascular Anesthesia|February 27, 2013
Volatile anaesthetic myocardial protection: a review of the current literatureE Lin, J A Symons
British Journal of Anaesthesia|June 24, 2006
Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysisJ A Symons, P S Myles
FEBS Letters|October 15, 1990
A soluble form of the interleukin-1 receptor produced by a human B cell lineJ A Symons, G W Duff
Cell|May 19, 1995
Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificityJ A Symons, A Alcamí, G L Smith
Rheumatology International|January 1, 1990
Interleukin 1 beta in synovial fluid is related to local disease activity in rheumatoid arthritisM Rooney, J A Symons, G W Duff
Archives of Virology. Supplementum|September 2, 1999
Immune modulation by proteins secreted from cells infected by vaccinia virusG L Smith, J A Symons, A Alcamí
Anaesthesia|December 21, 2002
Anaesthetists' attitudes towards awareness and depth-of-anaesthesia monitoringP S Myles, J A Symons, K Leslie
Journal of Virology|November 9, 2000
The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFNA Alcamí, J A Symons, G L Smith
FEBS Letters|January 29, 1990
Identification of an interleukin-1 beta binding protein in human plasmaJ A Eastgate, J A Symons, G W Duff
Cytokine|May 1, 1990
A soluble binding protein specific for interleukin 1 beta is produced by activated mononuclear cellsJ A Symons, J A Eastgate, G W Duff
Pageof 4